| Issue Date | Title | Author(s) |
| 2024 | Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectives | Akkuş, Erman; Arslan, Çağatay ; Ürün, Yüksel |
| 2023 | Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis | Soo, R.A.; Cho, B.C.; Kim, J.-H.; Ahn, M.-J.; Lee, K.H.; Zimina, A.; Orlov, S.; Hana Lee; Arslan, Çağatay |
| 2023 | Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium | Erol, Cihan; Yekeduz, Emre; Tural, Deniz; Karakaya, Serdar; Şentürk Öztaş, Nihan; Uçcar, Gökhan; Kılıçkap, Saadettin; Arslan, Çağatay |
| 2022 | Cutaneous metastasis of bladder urothelial carcinoma; A rare conditions | Oztuerk, Hakan; Yurtsever, Selin; Ozer, Arzum; Arslan, Cagatay ; Tekeli, Aysun; Pehlivan, Fatma Seher |
| 2023 | The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study | Güven, Deniz Can; Aykan, Musa Barış; Muglu, Harun; Bayram, Ertuğrul; Helvacı, Kaan; Dursun, Bengue; Celayir, Melisa; Arslan, Çağatay |
| 2023 | Efficacy of olaparib (ola) plus abiraterone (abi) vs placebo (pbo) plus abi in the non-BRCA mutation (non-BRCAm) subgroup of patients (pts) with metastatic castration-resistant prostate cancer (mCPRC) in the PROpel trial | Mehra, N.; Clarke, N. W.; Armstrong, A. J.; Oya, M.; Shore, N. D.; Procopio, G.; Guedes, J. D. C.; Arslan, Çağatay |
| 2023 | External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database | Yekeduz, Emre; Karakaya, Serdar; Erturk, Ismail; Tural, Deniz; Ucar, Gokhan; Oztas, Nihan Senturk; Arikan, Rukiye; Arslan, Çağatay |
| 2023 | Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice | Tural D.; Arslan C. ; Selcukbiricik F.; Olmez O.F.; Akar E.; Erman M.; Ürün Y. |
| 2022 | Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice. | Tural, Deniz; Arslan, Cagatay ; Selcukbiricik, Fatih; Olmez, Omer Fatih; Erman, Mustafa; Urun, Yuksel; Karadurmus, Nuri |
| 2022 | Modified docetaxel, cisplatin, and 5-fluorouracil combination regimen and capecitabine maintenance in metastatic gastric cancer: toxicity and efficacy results | Arslan, Cagatay ; Atilla, Fatos Dilan |
| 2023 | Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial | Saad, F.; Clarke, N.W.; Oya, M.; Shore, N.; Procopio, G.; Guedes, J.D.; Arslan, Çağatay |
| 2024 | Perceptions and expectations: A study on prognostic perception and quality of life in patients with metastatic renal and bladder cancer. | Bolek, Hatice; Arslan, Cagatay ; Başaran, Mert; Cicin, İrfan; Ozguroglu, Mustafa; Tural, Deniz; Ürün, Yüksel |
| 2023 | Perspectives and Knowledge about Fertility Preservation Strategies among Female Cancer Patients in Turkey | Emirdar, Volkan ; Karatasli, Volkan; Acet, Ferruh; Okay, Gulin ; Gode, Funda ; Karabulut, Alaattin; Arslan, Cagatay |
| 2021 | Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study | Arslan, Çağatay ; Kefeli, U.; Yildirim, E.; Isikdogan, A.; Karadurmus, N.; Karabulut, B.; Cicin, I. |
| 2021 | Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer. | Kefeli, Umut; Arslan, Cagatay ; Yildirim, Mahmut Emre; Isikdogan, Abdurrahman; Karadurmus, Nuri; Karabulut, Bulent; Cubukcu, Erdem |
| 2022 | The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study | Yekeduz, Emre; Tural, Deniz; Erturk, Ismail; Karakaya, Serdar; Erol, Cihan; Ercelep, Ozlem; Arslan, Cagatay |
| 2022 | Two Randomized Controlled Trials of Romiplostim for Chemotherapy-Induced Thrombocytopenia in Patients with Solid Tumors | Al-Samkari, Hanny; Geredeli, Caglayan; Arslan, Cagatay ; Korantzis, Ippokratis; Dogu, Gamze Gokoz; Nechaeva, Marina; Fernandez, Mercedes Salgado |
